Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06160492
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-08
First Post:
2023-11-27
Brief Title:
Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid 5-ALA
Sponsor:
Lees Pharmaceutical Limited
Organization:
Lees Pharmaceutical Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-27
First Submit QC Date:
December 6 2023
Study First Post Date:
2023-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-06
Last Update Post Date:
2023-12-08
Last Update Post Date Type:
ACTUAL